Exabis Library
Welcome to the e-CCO Library!
P289: Transcutaneous nonlinearity strain ultrasound differentiates early vs. advanced fibrotic intestine in vivo in the TNBS rat model and is feasible in patients with Crohn’s disease
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P290 Long-term disease outcome of ulcerative colitis (UC) in South Ostrobothnia, Finland with a follow-up time of 25 years
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P290: Compliance to vaccination guidelines in patients with immune-mediated inflammatory diseases: a cross-sectional, single-centre study
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P290: Determination of small-bowel patency in Crohn’s disease - a prospective study
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P290: Development of an artificial intelligence model using stool pictures for predicting endoscopic mucosal inflammation in patients with Ulcerative Colitis; KASID multicenter study
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:05 AM
P290: Evaluation of patients with retained patency capsule
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P290: Impact of concomitant 5-aminosalicylic acid therapy on vedolizumab efficacy and safety in Inflammatory Bowel Disease
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P290: Pre-operative anti-glycan antibodies and anti-glycan antibodies developing after pouch surgery in patients with ulcerative colitis correlate with pouch complications: a prospective longitudinal case series
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM
P290: Therapeutic requirements in patients with Ulcerative Proctitis. Is it necessary immunosuppressive therapy in these patients?
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM
P291 Diagnostic utility of the neutrophil-platelet rate (NeuPla) as a marker of activity in patients with ulcerative colitis
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P291: Can the prognostic index be a predicting factor for mortality and morbidity in intestinal resection of patients with ulcerative colitis?
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P291: Effect of the preconception steroid-free remission period on disease activity during pregnancy and birth outcomes in women with Ulcerative Colitis: a retrospective cohort study
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM
P291: Improvements in access to IBD care following the implementation of a novel tiered triage model
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P291: Long term outcomes of children with ulcerative colitis after acute severe colitis: a multicenter study from the GETAID pédiatrique group
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:05 AM
P291: Pharmacokinetics, safety, and tolerability of etrasimod (APD334) in subjects with mild, moderate, or severe hepatic impairment: a single-dose, open-label, parallel-group study
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P291: Proteinase 3-antineutrophil cytoplasmic antibodies (PR3-ANCA) would be a predictive biomarker for the clinical course of ulcerative colitis
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P291: Sacroiliitis is under-recognised in inflammatory bowel disease and is associated with previous arthritis and inflammatory Crohn’s phenotype
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM
P292 Inflammatory bowel disease and their implications in Roma ethnicity: A preliminary study
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P292: Association of golimumab trough concentrations during maintenance with endoscopic and histologic remission in patients with ulcerative colitis.
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM
P292: Complications in elderly-onset Inflammatory Bowel Diseases – A population-based study from the epidemiological database of the Israeli IBD Research Nucleus (Epi-IIRN)
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:05 AM